Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clene Inc. - Common Stock (NQ:CLNN)

3.800 -0.120 (-3.06%)
Delayed Quote Updated: 9:46 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clene Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Clene's Neurogenerative Candidate Shows Potential For Improved Long-Term Survival ↗
Clene Inc. (NASDAQ: CLNN) released long-term follow-up data for patients treated with CNM-Au8 30mg for up to 133 weeks in the  
Via Benzinga
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Significant Long-Term Survival Improvement Data from ALS Trial
Via Investor Brand Network
News headline image
Expert Ratings for Clene ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Where Clene Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Clene Shares Are Nosediving ↗
Clene Inc. (NASDAQ: CLNN) shares are trading lower by 13.81% to $0.90 Friday morning after the company announced pricing of a $40 million public offering. 
Via Benzinga
News headline image
Where Clene Stands With Analysts ↗
 
Via Benzinga
News headline image
Expert Ratings for Clene ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Clene And 2 Other Stocks Under $3 Insiders Are Aggressively Buying ↗
The Dow Jones closed higher by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $40M Public Offering
Via Investor Brand Network
News headline image
Uber To Rally Around 55%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Rosenblatt boosted the price target for Lumentum Holdings Inc. (NASDAQ: LITE) from $48 to $67. Rosenblatt analyst Mike Genovese maintained a Neutral rating. Lumentum shares fell 1.3% to $60.56 in... 
Via Benzinga
News headline image
Clene: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Analyst Expectations for Clene's Future ↗
 
Via Benzinga
News headline image
Analyst Ratings for Clene ↗
 
Via Benzinga
News headline image
Clene's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June ↗
U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P... 
Via Benzinga
News headline image
Clene's CNM-Au8 Shows Significant Reduction In Neurodegenerative Biomarker, Raises $40M Via Equity ↗
Clene Inc (NASDAQ: CLNN) reported new data demonstrating a statistically significant reduction of plasma neurofilament light chain (NfL) levels for CNM-Au8 treated participants compared to placebo... 
Via Benzinga
News headline image
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781. 
Via Benzinga
News headline image
The Latest Analyst Ratings for Clene ↗
 
Via Benzinga
News headline image
Crude Oil Rises; Adobe Posts Upbeat Results ↗
U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket ↗
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Gilead Sciences To Rally Around 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
Morgan Stanley raised the price target for DraftKings Inc. (NASDAQ: DKNG) from $23 to $25. Morgan Stanley analyst Stephen Grambling maintained an Overweight rating. DraftKings shares fell 0.2% to close... 
Via Benzinga
News headline image
Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday ↗
Credit Suisse boosted the price target for The Boeing Company (NYSE: BA) from $200 to $220. Credit Suisse analyst Scott Deuschle maintained a Neutral rating on the stock. Boeing shares fell 0.4% to... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023 ↗
 
Via Benzinga
News headline image
Clene's Lead Amyotrophic Lateral Sclerosis Shows Improved Function, Slowed Disease Progression ↗
 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.